C4 Therapeutics, Inc. earnings per share and revenue

CCCC earnings per share for the last quarter are -0.41 USD whereas the estimation was -0.36 USD which accounts for -12.37% surprise. Företagets omsättning för samma period uppgår till 3.04 M USD trots den uppskattade siffran 11.99 M USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 4.78 M USD. Also watch annual changes over time to get a bigger picture of CCCC earnings per share and revenue dynamics.